SYNTAX System
DNA-on Demand with benchtop convenience and same-day results.
Receive your quote directly from the manufacturer.
Excellent results and can’t survive without this instrument
Genetic engineering and biotechnology
Product is environmentally friendly and cost effective and cost efficient
Review Date: 25 Mar 2022 | DNA Script
DNAScript is a game changer in oligo synthesis.
Life Sciences, synthetic biology
Innovative machine for the synthesis of DNA oligos, outstanding customer service, and really fast to obtain the product.
Review Date: 24 Jan 2022 | DNA Script
Introducing the SYNTAX System, the first DNA printer powered by enzymatic synthesis. Designed for speed, reliability and ease of use, the SYNTAX System enables you to produce your own high quality ssDNA oligo, up to 120 mer, overnight and in house. It eliminate external suppliers dependency and delivery constraints, allow to keep your IP in house, and it gives you the ability to respond faster, iterate with confidence, and eliminate uncertainty from your workflows.
System Capabilities
- Automated synthesis with little hands on time for run preparation
- Intuitive software to design, set up and visualise runs
- Performed by Enzymatic DNA Synthesis: reduce chemical waste , no need of specialized infrastructure
- From 96 to 384 oligos synthesised in parallel
- Synthesize oligos overnight for next-day use
Oligo Specifications
- Oligos from 15 nt to 120 nt oligos
- Default 5’-phosphate
- Oligos ready-to-use right off the SYNTAX (desalted and in aqueous solution)
- Oligo quality on par with gold‑standard providers
- From $0.11 by nucleotide
Applications
Ready-to-use oligos for molecular biology and genomics applications, including
- PCR, dPCR
- qPCR primers and probes
- Sanger sequencing
- site-directed mutagenesis
- Gene assembly
Brochures
Own the capability and eliminate uncertainty with SYNTAX
This product brochure introduces SYNTAX from DNA Script, an automated in-house DNA synthesis platform that enables laboratories to produce high-quality single-stranded DNA oligonucleotides on demand. Discover how enzymatic DNA synthesis helps eliminate vendor dependencies, reduce lead times, and improve confidentiality while accelerating research workflows. Explore how the platform’s reliability, ease of use and kit options support applications including gene synthesis, protein mutagenesis, qPCR, and next-generation sequencing.
Resource details:
Resource type: Product brochure
Page count: 7
Read time: 8 mins
SYNTAX System
DNA Script introduces a new paradigm in oligo synthesis, the SYNTAX System, powered by Enzymatic DNA Synthesis (EDS) technology to accelerate life science innovation. Designed for ease of use, productivity, convenience, control, and confidentiality, the SYNTAX System enables automated nucleic acid synthesis within a benchtop solution. In this application note, you can find all applications and benefits of the technology.
Enzymatic DNA synthesis
This resource describes DNA Script's Enzymatic DNA Synthesis (EDS) technology, which enables automated, in-house production of DNA oligonucleotides using engineered enzymes rather than traditional phosphoramidite chemistry. The approach is designed to provide faster access to custom DNA while supporting a range of genomics and molecular biology applications.
Resource details:
Resource type: Whitepaper
Page count: 4
Read time: 6 mins
Gene assembly
DNA Script demonstrated successful assembly of EGFP and mRFP reporter genes using oligos produced with its Enzymatic DNA Synthesis (EDS) technology and SYNTAX™ System. The study shows high gene assembly success rates and accelerated timelines, enabling sequence-verified clones in as little as three days.
Resource details:
Resource type: Application note
Page count: 12
Read time: 18 mins
SARS-CoV-2 spike protein mutagenesis
DNA Script demonstrated the use of its SYNTAX™ System and Enzymatic DNA Synthesis (EDS) technology to generate custom oligos for SARS-CoV-2 spike protein mutagenesis. Discover how the workflow enabled rapid production and verification of optimized and variant spike protein expression plasmids, supporting recombinant protein research and synthetic biology applications.
Resource details:
Resource type: Application note
Page count: 10
Read time: 15 mins
SARS-CoV-2 amplicon sequencing
In this application note, DNA Script demonstrates the use of primers produced with its novel Enzymatic DNA Synthesis (EDS) technology for whole-genome amplicon sequencing and phylogenetic analysis of SARS-CoV-2 isolates using the ARTIC network protocol.
Explore how this technology enables decentralized, same-day, on-demand DNA oligo synthesis using a benchtop printer in a standard laboratory environment, without any specialized technical skills required.
Resource details:
Resource type: Application note
Page count: 7
Read time: 11 mins
DNA Script's Enzymatic DNA Synthesis technology
Learn about Enzymatic DNA Synthesis (EDS) technology from DNA Script, an innovative approach to DNA production that uses enzymes rather than traditional chemical synthesis methods. Discover how EDS technology enables rapid, on-demand oligo synthesis, supporting greater flexibility, sustainability, and efficiency in modern research laboratories.
Own your gene synthesis workflow with in-house oligo synthesis enabled by SYNTAX
This webinar explores the advantages of in-house oligo synthesis using the SYNTAX platform™ from DNA Script. Discover how this technology revolutionizes gene writing for therapeutic development, offering enhanced speed, reliability, and IP control. Learn about the SYNTAX workflow, including error correction and assembly methods, and see how it delivers high-quality results comparable to outsourced services.
DNA Script SYNTAX System workflow
Explore the SYNTAX™ System workflow from DNA Script, designed to simplify and automate in-house oligonucleotide synthesis. Discover how researchers can move seamlessly from sequence design to oligo production, reducing turnaround times and enabling faster iteration of gene synthesis and molecular biology workflows.
DNA Script expands access to on-demand DNA synthesis in India through distributor agreement with Imperial Life Sciences
Brings decentralized, in-house DNA synthesis capabilities to researchers in a rapidly growing biotechnology market
DNA Script launches early access program for latest advancements to the SYNTAX Platform and Enzymatic DNA Synthesis Technology
Program participants will receive early access to the upcoming release of kits designed to print longer oligos and enable labeling with fluorophores, quenchers, and biotin
Meet your winners in the 2022 Scientists’ Choice Awards for Life Sciences
Beckman Coulter Life Sciences, Zymo Research, and Corning Life Sciences among those recognized at AACR 2022
5 upcoming webinars to accelerate your research
Discover the latest tools and techniques to expand your research capacity with expert-led presentations on flow cytometry, epigenomics, expression vectors, and more
Free masterclass on oligo printing via enzymatic DNA synthesis
In this on-demand SelectScience webinar, explore how the DNA script SYNTAX System can be used in enzymatic DNA synthesis
5 upcoming webinars to support your research
Discover insights on topics from COVID-19 testing, chemical analysis, SARS-CoV-2 variants, and preparative HPLC
7 upcoming webinars to support your research
Discover insights on topics from lab automation to immuno-oncology, DNA printing technology, toxicology, and more
